EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bridging treatment prior to chimeric antigen receptor T‐cell therapy in multiple myeloma

Susan Bal iD, Luciano J Costa iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19227 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Susan Bal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Multiple Myeloma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autologous patient‐derived adoptive T‐cell therapies have revolutionized the management of relapsed multiple myeloma (MM). However, the current manufacturing and quality control processes result in lengthy vein‐to‐vein time, making bridging therapy necessary for most patients. Yet the decision and choice of optimal bridging therapy are complex in the heavily pretreated relapsed MM patient. In this perspective piece, the authors provide their approach and considerations while selecting an optimal bridging regimen before autologous chimeric antigen receptor T‐cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenMultiple MyelomaHumansT-LymphocytesImmunotherapy, AdoptiveCell- and Tissue-Based TherapyB-Cell Maturation Antigen

Stichwörter der Autor:innen

cellular immunologymultiple myelomamyeloma therapy

Substanzen

Receptors, Chimeric AntigenB-Cell Maturation Antigen

Autor:innen und Institutionen

  • Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Susan Bal, Luciano J Costa

Zitieren

APA

Bal, S., & Costa, L. J. (2024). Bridging treatment prior to chimeric antigen receptor T‐cell therapy in multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.19227

Vancouver

Bal S, Costa LJ. Bridging treatment prior to chimeric antigen receptor T‐cell therapy in multiple myeloma. British Journal of Haematology. 2024. doi:10.1111/bjh.19227

BibTeX
@article{Bal2024,
  author = {Bal, Susan and Costa, Luciano J},
  title = {Bridging treatment prior to chimeric antigen receptor T‐cell therapy in multiple myeloma},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19227}
}
Kostenlos starten →